At a glance
ClinicalIndex Comparison RecordN/ACompleted· 271 enrolled
Drug / intervention
Senofilcon C +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Study of Approved Contact Lenses
In Brief
A clinical study evaluating Senofilcon C and Samfilcon A for Myopia. Completed, enrolled 271 participants across 11 sites.
Detailed Summary
Evaluation of Johnson \& Johnson Acuvue Vita (senofilcon C) soft contact lenses to the Bausch + Lomb Ultra (samfilcon A) soft contact lenses
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
Primary CompletionNov 2017
First PostedNov 2017
Study CompletionDec 2017
TodayJul 2026
First PostedNov 22, 2017
Enrollment StartOct 23, 2017
Primary CompletionNov 10, 2017
Study CompletionDec 8, 2017
TodayJul 2, 2026
Enrollment to primary: 17 daysPosted 8.6 years ago
Interventions
Senofilcon Cdevice
Senofilcon C Contact Lens
Samfilcon Adevice
Samfilcon A Contact Lens